Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#28 in Laval
#3,466 in Canada
Bellus Health Inc.
Forward Citations = 21
12 inventors:
Bellus Health Inc.
% Expired Patents = 25.0
EPO Patents = 3
Forward Citations = 21
Loading Chart...
Loading Chart...
12 inventors (with patents filed for the assignee):
Xianqi Kong (4 out of 42 patents)
Mohamed Atfani (4 out of 7 patents)
Abderrahim Bouzide (4 out of 16 patents)
4. Benoit Bachand (4 out of 11 patents)
5. Sophie Levesque (4 out of 10 patents)
6. David Migneault (4 out of 15 patents)
7. Isabelle Valade (4 out of 9 patents)
8. Xinfu Wu (4 out of 11 patents)
9. Daniel Delorme (4 out of 38 patents)
10. Stephane Ciblat (3 out of 34 patents)
11. Francine Gervais (1 out of 10 patents)
12. Bita Samim (1 out of 2 patents)
13. Walter A Szarek (19 patents)
14. Wendy Hauck (2 patents)
15. Pavel Hamet (2 patents)
4 patents:
Company Overview
Bellus Health Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. The company's lead product candidate, BLU-5937, is being developed for the treatment of chronic cough and has the potential to be a first-in-class therapy. Bellus Health is committed to improving the lives of patients suffering from these debilitating conditions through innovative research and development.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bellus Health Inc.. Retrieved from https://idiyas.com/company/bellus-health
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]